Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-13

Clinical Trial Update: Comparing Blood Loss and Visualization After the Preoperative Use of Topical 0.05% Oxymetazoline Versus 1:1000 Epinephrine Prior to Endoscopic Sinus Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial comparing topical oxymetazoline versus epinephrine as preoperative vasoconstrictors for endoscopic sinus surgery; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epinephrine 1:1000 (epinephrine)
  • Oxymetazoline 0.05% (topical) (oxymetazoline)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Endoscopic Sinus Surgery, Nasal Polyps | Phase 4 | Status: COMPLETED | Results posted: 2021-01-13